Inhibition of Breast Cancer Metastasis Via PITPNM3 by Pachymic Acid |
Hong, Ri
(Department of Breast, the First School of Clinical Medicine, Zhejiang Chinese Medical University)
Shen, Min-He (Department of Oncology, the First School of Clinical Medicine, Zhejiang Chinese Medical University) Xie, Xiao-Hong (Department of Breast, the First School of Clinical Medicine, Zhejiang Chinese Medical University) Ruan, Shan-Ming (Department of Oncology, the First School of Clinical Medicine, Zhejiang Chinese Medical University) |
1 | Chen J, Yao Y, Gong C et al (2011). CCL18 from tumorassociated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell, 19, 541-55. DOI |
2 | Clines GA, Guise TA (2005). Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer, 12, 549-83. DOI |
3 | Fougere M, Gaudineau B, Barbier J et al (2010). NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene. Oncogene, 29, 2292-301. DOI |
4 | Gapter L, Wang Z, Glinski J, Ng K-y (2005). Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos. Biochem Biophys Res Commun, 332, 1153-61. DOI ScienceOn |
5 | Huang YC, Chang WL, Huang SF, et al (2010). Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation. Eur J Pharmacol, 648, 39-49. DOI |
6 | Kaminaga T, Yasukawa K, Kanno H, et al (1996). Inhibitory effects of lanostane-type triterpene acids, the components of Poria cocos, on tumor promotion by 12-O-tetradecanoylphorbol- 13-acetate in two-stage carcinogenesis in mouse skin. Oncology, 53, 382-5. DOI ScienceOn |
7 | Lev S, Hernandez J, Martinez R, et al (1999) Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein. Mol Cell Biol, 19, 2278-88. DOI |
8 | Martinez FO, Helming L, Gordon S (2009). Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol, 27, 451-83. DOI |
9 | Mundy GR (2002). Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer, 2, 584-93. DOI ScienceOn |
10 | Narita D, Seclaman E, Ursoniu S, et al (2011). Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls. Rom J Morphol Embryol, 52, 1261-7. |
11 | Ukiya M, Akihisa T, Tokuda H, et al (2002). Inhibition of tumorpromoting effects by poricoic acids G and H and other lanostane-type triterpenes and cytotoxic activity of poricoic acids A and G from Poria cocos. J Nat Prod, 65, 462-5. DOI ScienceOn |
12 | Wang X, Lu H, Urvalek AM, et al (2011). KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene, 30, 1901-11. DOI |
13 | Zohny SF, Fayed ST (2010). Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer. Med Oncol, 27, 1246-53. DOI |